MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash and cashequivalents$319,850K (5.56%↑ Y/Y)Accounts receivable, net$277,459K (39.55%↑ Y/Y)Inventories, net$37,883K (105.43%↑ Y/Y)Prepaid and othercurrent assets$21,377K (30.84%↑ Y/Y)Total current assets$656,569K (22.35%↑ Y/Y)Intangible asset, net$37,358K (-14.58%↓ Y/Y)Non-current inventory andother assets$35,447K (46.17%↑ Y/Y)Right-of-use asset -operating lease$19,157K (-14.75%↓ Y/Y)Goodwill$12,042K (0.00%↑ Y/Y)Equipment, net$874K (31.03%↑ Y/Y)Total assets$761,447K (19.02%↑ Y/Y)Total liabilities andstockholders equity$761,447K (19.02%↑ Y/Y)Total liabilities$678,143K (19.66%↑ Y/Y)Total stockholdersequity$83,304K (14.00%↑ Y/Y)Accumulated deficit-$1,421,817K (-15.58%↓ Y/Y)Total currentliabilities$460,446K (34.59%↑ Y/Y)Loan payable,long-term$117,958K (0.36%↑ Y/Y)Contingent consideration,non-current$69,135K (-13.21%↓ Y/Y)Operating leaseliability, long-term$21,574K (-8.68%↓ Y/Y)Finance leaseliability, long-term$9,030K (138.13%↑ Y/Y)Additional paid-in capital$1,505,116K (15.49%↑ Y/Y)Common stock, 0.0001par value per share...$5K (0.00%↑ Y/Y)Accrued expenses andother current...$299,632K (75.32%↑ Y/Y)Accounts payable$78,969K (-13.82%↓ Y/Y)Short-term borrowings$70,000K (0.00%↑ Y/Y)Contingent consideration,current$11,199K (21.31%↑ Y/Y)Operating leaseliability, current portion$646K (91.69%↑ Y/Y)
Balance Sheet

Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. (AXSM)

source: myfinsight.com